CBT
SBIO icon

Central Bank & Trust’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Central Bank & Trust’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$32K – 261
2020
Q1 		$32K Hold
1,000
– – 0.01% 190
2019
Q4 		$42K Hold
1,000
– – 0.01% 191
2019
Q3 		$32K Buy
+1,000
New +$35.2K 0.01% 194

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Central Bank & Trust's SBIO Position: Q2 2020 in Review

Central Bank & Trust sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2020, closing a stake of 1,000 shares — an estimated $32K sold.

Central Bank & Trust first reported a position in SBIO in Q3 2019 and held it in 3 quarters. The position peaked at $42K in Q4 2019. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2020.

  • Central Bank & Trust reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2020 after selling out during the quarter.
  • Central Bank & Trust sold 1,000 ALPS Medical Breakthroughs ETF shares in Q2 2020, an estimated $32K.
  • Central Bank & Trust first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and held it in 3 quarters.
  • Central Bank & Trust's ALPS Medical Breakthroughs ETF position peaked at $42K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2020.

Based on Central Bank & Trust's 13F filing for Q2 2020, filed 15 Jul 2020.